Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival

Malignant pleural mesothelioma is a rare and aggressive malignancy of the pleura correlated with exposure to asbestos, with a medium survival of 11–12 months after diagnosis. A case of a 67-year-old male who had previously worked in the asbestos industry and is a current smoker is reported. The comp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zarogoulidis, Paul, Mavroudi, Maria, Porpodis, Konstantinos, Domvri, Kalliopi, Sakkas, Antonios, Machairiotis, Nikolaos, Stylianaki, Aikaterini, Tsiotsios, Anastasios, Courcoutsakis, Nikolaos, Zarogoulidis, Konstantinos
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3463410/
https://ncbi.nlm.nih.gov/pubmed/23055748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S36915
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars